Haoning Guo

机构：Mianyang Third People's Hospital

发表论文 5 篇 · 总被引 56 次 · h-index 4

代表论文

Neurological Adverse Events Associated With Esketamine: A Disproportionality Analysis for Signal Detection Leveraging the FDA Adverse Event Reporting System (2022 · Frontiers in Pharmacology · 被引 30)
Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system (2022 · Frontiers in Pharmacology · 被引 13)
Comparative safety and tolerability of ketamine and esketamine for major depressive disorder: a systematic review and meta-analysis (2025 · Frontiers in Pharmacology · 被引 9)
Combining untargeted and targeted metabolomic profiling reveals principal differences between osteopenia, Osteoporosis and healthy controls (2025 · Aging Clinical and Experimental Research · 被引 4)
Combining Untargeted and Targeted Metabolomic Profiling Reveals Principal Differences between Osteopenia, Osteoporosis and Healthy Controls (2024 · Research Square)